When can a child be diagnosed with dengue hemorrhagic fever?

Diagnosis of Dengue Hemorrhagic Fever in Children

A child can be diagnosed with dengue hemorrhagic fever when they meet all four WHO criteria: confirmed dengue infection, hemorrhagic manifestations (positive tourniquet test or spontaneous bleeding), thrombocytopenia (≤100,000 cells/mm³), and objective evidence of plasma leakage (hemoconcentration ≥20%, pleural effusion, ascites, or hypoalbuminemia).

Core Diagnostic Criteria

The WHO 1997 classification requires all four components to diagnose DHF 1:

• Laboratory-confirmed dengue infection – either by RT-PCR (within first 5 days), NS1 antigen detection, or positive IgM/IgG serology (after day 5) 2
• Hemorrhagic tendency – demonstrated by positive tourniquet test (≥20 petechiae per 2.5 cm² area) or spontaneous bleeding (epistaxis, gingival bleeding, hematemesis, melena) 1, 3
• Thrombocytopenia – platelet count ≤100,000 cells/mm³ 1, 3
• Evidence of plasma leakage – shown by hemoconcentration (≥20% rise in hematocrit), pleural effusion, ascites, or hypoalbuminemia 1, 4

Timing of Diagnosis

The diagnosis typically becomes apparent during the critical phase (days 3-7 of illness), when plasma leakage begins 2:

• The febrile phase (days 1-3) shows high fever but may not yet demonstrate plasma leakage 2
• The critical phase (days 3-7) is when DHF manifests with defervescence, plasma leakage, and potential progression to shock 2
• Early diagnosis requires close monitoring of hematocrit and platelet counts during this transition 1, 3

Special Considerations in Infants

Diagnosing DHF in infants under 1 year presents unique challenges 5:

• Tourniquet test is less reliable – only 50.2% positive in infants versus 92.2% in older children 5
• Leukopenia is less common – only 26.8% of infants show WBC ≤5,000 cells/mm³ versus 71.9% in children 5
• Unusual presentations are more frequent – including URI symptoms (4.5%), diarrhea (13.1%), convulsions (12.7%), and encephalopathy (4.1%) 5
• Hepatic dysfunction is more prominent – with higher AST/ALT elevations and prolonged PT 5
• Plasma leakage may be less severe but shorter in duration – requiring judicious fluid management to avoid overload (9% complication rate versus 3.6% in children) 5

Diagnostic Performance & Pitfalls

The WHO DHF criteria demonstrate 62% sensitivity and 92% specificity for identifying dengue cases requiring intervention 1:

• Plasma leakage and thrombocytopenia are the most specific components for identifying severe cases requiring treatment 1
• Hemorrhagic manifestations alone do not reliably differentiate DF from DHF – bleeding can occur in dengue fever without meeting full DHF criteria 1
• 32% of children requiring significant intervention (fluid resuscitation, blood transfusion) do not meet strict WHO DHF criteria, highlighting that severe dengue exists on a spectrum 1

Clinical Markers by Severity

When comparing DHF to dengue shock syndrome (DSS), specific findings predominate 3:

• DHF is characterized by – bleeding manifestations (29.4%), positive tourniquet test (47%), and significantly low platelet count (mean 32,588/mm³) 3
• DSS is marked by – hypotension (90%), tachycardia (90.9%), shock (90.9%), hepatomegaly (72.7%), hypoalbuminemia (mean 27.82 g/L), and metabolic acidosis (low TCO2) 3
• Neutropenia is more significant in DSS (72.7%) 3

Practical Diagnostic Algorithm

1. Confirm dengue infection – use RT-PCR or NS1 if ≤5 days from onset; use IgM/IgG if >5 days 2
2. Assess for hemorrhagic manifestations – perform tourniquet test and examine for spontaneous bleeding 1
3. Monitor platelet count – check daily; DHF requires ≤100,000/mm³ 1, 3
4. Document plasma leakage – serial hematocrit measurements (≥20% rise), chest X-ray for effusion, ultrasound for ascites, or serum albumin 1, 4
5. In infants, maintain high suspicion despite negative tourniquet test or normal WBC, and watch for atypical presentations 5